Basic information Safety Related Supplier

ChemicalBook Product Catalog Biochemical Engineering Inhibitors Neuronal Signaling Dopamine Receptor agonists Pergolide mesylate salt

1/1

Pergolide mesylate salt

$ 1.00 /1KG

Min. Order1G
Purity98%
Cas No66104-23-2
Supply Ability100KG
Update time2019-07-06

career henan chemical co

career henan chemical co

7YR

China

show more

Chemical Properties

Product Name	Pergolide mesylate salt
CAS No	66104-23-2
EC-No
Min. Order	1G
Purity	98%
Supply Ability	100KG
Release date	2019/07/06

AD68

Pergolide mesylate salt Basic information

Product Name:	Pergolide mesylate salt
Synonyms:	8BETA-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE MESYLATE SALT;8-BETA-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE MONOMETHANE SULFONATE;Pergolide mesylate EPIV;Pergolidemetylsulfonate;(8b)-8-[(Methylthio)methyl]-6-propylergoline Mesylate;Celance;Nopar;Permax
CAS:	66104-23-2
MF:	C20H30N2O3S2
MW:	410.59
EINECS:
Product Categories:	Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;API;LOCOID
Mol File:	66104-23-2.mol

Pergolide mesylate salt Chemical Properties

Melting point	252-254°C
alpha	aD20 between -18.0° and -23.0° (c = 10 mg/ml in DMF)
storage temp.	−20°C
solubility	ethanol: soluble2mg/mL
pka	pKa (66% DMF) 7.8(at 25℃)
color	white
CAS DataBase Reference	66104-23-2(CAS DataBase Reference)

Safety Information

Hazard Codes	T+
Risk Statements	28
Safety Statements	28-36/37-45
RIDADR	UN 1544
RTECS	KE6345000

MSDS Information

Pergolide mesylate salt Usage And Synthesis

Chemical Properties	White to Off-White Solid
Uses	A dopaminergic agonist that also decrease plasma prolactin concentrations. An antiparkinsonian agent
Uses	glucocorticoid, antiinflammatory
Uses	dopamine receptor agonist, anti-Parkinson's agent
Definition	ChEBI: A methanesulfonate salt obtained from pergolide by mixing eqimolar amount of pergolide and methanesulfonic acid. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it i used in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction.

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book